News

$ 27.89 Billion Growth in Global Legal Cannabis Market During 2020-2024 | Featuring Key Vendors Including Aphria Inc., Aurora Cannabis Inc., and Bhang Corp. | Technavio

February 2, 2021

LONDON–(BUSINESS WIRE)–Technavio announces the release of its latest report on the legal cannabis market. The market is segmented by product (medical and recreational) and geography (APAC, Europe, MEA, North America, and South America). The report offers an in-depth analysis of recent developments, changes in market regulations, product approvals, product launches, and the market behavior across…

Details

Botanix | World First Human Clinical Study Shows Synthetic CBD Formula Eradicates Staphylococcus Aureus

February 2, 2021

PHILADELPHIA & SYDNEY–(BUSINESS WIRE)–Clinical stage synthetic cannabinoid company Botanix Pharmaceuticals Limited has today published positive data from a world first human clinical study, examining the safety, tolerability and efficacy of its BTX 1801 antimicrobial product for the eradication of Staphylococcus Aureus (Staph). Staph, also called golden staph, is a common bacterium that lives on the…

Details

Heritage Cannabis Announces Pricing of Overnight Marketed Public Offering of Units

February 2, 2021

TORONTO–(BUSINESS WIRE)–Heritage Cannabis Holdings Corp. (CSE: CANN) (the “Company“) is pleased to announce that it has priced its previously announced overnight marketed public offering of units (each, a “Unit“) of the Company (the “Offering“). The Company intends to issue up to 86,000,000 Units at a price of $0.14 per Unit (the “Issue Price“) for aggregate…

Details

Conifer Health Names Dina Dunn Chief Human Resources Officer

February 2, 2021

FRISCO, Texas–(BUSINESS WIRE)–Conifer Health Solutions, a subsidiary of Tenet Healthcare Corporation (NYSE: THC), announced today Dina Dunn will move into the company’s chief human resources officer position, providing critical support on the company’s growth and priority needs for the planned spinoff into a publicly traded company. “Dina is admired by her teams for her tremendous…

Details

Organigram Announces Executive Changes

February 2, 2021

MONCTON, New Brunswick–(BUSINESS WIRE)–Organigram Holdings Inc. (“Organigram” or the “Company”) (TSX: OGI) (NASDAQ: OGI) announces Matt Rogers, Senior Vice President, Operations, will be leaving Organigram at the end of May 2021 to pursue other interests. Organigram would like to thank Matt for his efforts helping Organigram grow from a licensed producer of medical cannabis to…

Details

Philippines CBD Regulatory Report 2021 – ResearchAndMarkets.com

February 2, 2021

DUBLIN–(BUSINESS WIRE)–The “Regulatory Report: Philippines CBD” report has been added to ResearchAndMarkets.com’s offering. Hemp is considered to be the equivalent of cannabis in the Philippines and is, therefore, a prohibited drug, carrying severe penalties for its cultivation, manufacture, sale, importation, possession and use under Republic Act No. 9165, known as the Comprehensive Dangerous Drugs Act…

Details

Macedonia CBD Regulatory Report 2021: Import and Export Requirements, Medical Cannabis, Recreational Cannabis, Relevant Laws & Relevant Bodies – ResearchAndMarkets.com

February 2, 2021

DUBLIN–(BUSINESS WIRE)–The “Regulatory Report: North Macedonia CBD” report has been added to ResearchAndMarkets.com’s offering. Hemp cannot currently be cultivated or processed for any purpose in North Macedonia. The use of non-viable hemp seeds is not restricted. In December 2019, the Ministry of Health presented the draft of the new Law on Control of Drugs and…

Details

HempFusion Wellness Inc. Becomes Exclusive CBD and Probiotics Sponsor of Loenbro Motorsports for 2021 Racing Season

February 2, 2021

DENVER–(BUSINESS WIRE)–HempFusion Wellness Inc. (TSX:CBD.U) (“HempFusion” or the “Company”), is pleased to announce an exclusive partnership with Loenbro Motorsports, one of the world’s leading race teams, making HempFusion CBD, a leading brand utilizing the power of whole-food hemp nutrition, and Probulin, one of the fastest growing probiotic brands in the U.S. according to SPINs reported…

Details

Cyprus CBD Regulatory Report 2020: Import and Export Requirements, Medical Cannabis, Recreational Cannabis, Relevant Laws, Relevant Bodies – ResearchAndMarkets.com

February 2, 2021

DUBLIN–(BUSINESS WIRE)–The “Regulatory Report: Cyprus CBD” report has been added to ResearchAndMarkets.com’s offering. CBD is considered a medicine in Cyprus and any CBD-infused product would be classified as a medicinal product. The report covers the current regulatory regime in place. The Cypriot legal framework distinguishes between industrial hemp and narcotic cannabis. In Cyprus, drugs are…

Details

Ireland CBD Regulatory Report 2020: Import and Export Requirements, Medical Cannabis, Recreational Cannabis, Relevant Laws & Relevant Bodies – ResearchAndMarkets.com

February 2, 2021

DUBLIN–(BUSINESS WIRE)–The “Regulatory Report: Ireland CBD” report has been added to ResearchAndMarkets.com’s offering. This report provides a comprehensive overview of the current regulatory regime for CBD, hemp and it’s products in Ireland, covering all aspects of law as well as providing a list of all relevant laws and bodies, and information relating to Ireland’s medical…

Details

Ecuador CBD Regulatory Report 2020: Import and Export Requirements, Medical Cannabis, Recreational Cannabis, Relevant Laws & Relevant Bodies – ResearchAndMarkets.com

February 2, 2021

DUBLIN–(BUSINESS WIRE)–The “Regulatory Report: Ecuador CBD” report has been added to ResearchAndMarkets.com’s offering. This report provides a detailed overview of the current regulatory regime in place for hemp and CBD in Ecuador, as well as information on medical and recreational cannabis. The Organic Law for the Comprehensive Prevention of the Socio-Economic Phenomenon of Drugs and…

Details

Celyad Oncology Announces February 2021 Conference Schedule

February 1, 2021

MONT-SAINT-GUIBERT, Belgium–(BUSINESS WIRE)–Regulatory News: Celyad Oncology SA (Euronext & Nasdaq: CYAD), a clinical-stage biotechnology company focused on the discovery and development of chimeric antigen receptor T cell (CAR T) therapies for cancer, today announced that the company plans to participate at the following conferences in February 2021: CAR-TCR Digital Summit Europe Date: Wednesday, February 17,…

Details